跳至主要内容
临床试验/IRCT20211130053229N1
IRCT20211130053229N1招募中1 期

Comparison of the effect of intravitreal injection of Bevacizumab (Stevenet) alone with intravitreal injection of Bevacizumab and Triamcinolone in the treatment of diabetic macular edema with a thickness greater than 500 microns in patients referred to Shafa Hospital.

Kerman University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with clinically significant DME according to ETDRS criteria
  • Patients with clinically significant DME based on criteria of central thickness greater than 500 microns

排除标准

  • History of previous DME treatment (focal or panretinal laser coagulation or IVB or IVT)
  • Eye surgery
  • Glaucoma or ocular hypertension
  • monocular vision
  • Significant media opacity
  • The patient's absence in follow-up in the following weeks

研究者

相似试验